Neurodegenerative disease: New leads for Parkinson's disease

Comment

Katie Kingwell. Nat Rev Neurosci. 2010 Oct.

. 2010 Oct;11(10):666.

doi: 10.1038/nrn2918.

No abstract available

Comment on

Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.
Lee BD, Shin JH, VanKampen J, Petrucelli L, West AB, Ko HS, Lee YI, Maguire-Zeiss KA, Bowers WJ, Federoff HJ, Dawson VL, Dawson TM. Lee BD, et al. Nat Med. 2010 Sep;16(9):998-1000. doi: 10.1038/nm.2199. Epub 2010 Aug 22. Nat Med. 2010. PMID: 20729864 Free PMC article.

Quality of life of patients with Parkinson's disease and neurodegenerative dementia: A nationally representative study.
Chekani F, Bali V, Aparasu RR. Chekani F, et al. Res Social Adm Pharm. 2016 Jul-Aug;12(4):604-13. doi: 10.1016/j.sapharm.2015.09.007. Epub 2015 Sep 28. Res Social Adm Pharm. 2016. PMID: 26508270
Welding occupations and mortality from Parkinson's disease and other neurodegenerative diseases among United States men, 1985-1999.
Stampfer MJ. Stampfer MJ. J Occup Environ Hyg. 2009 May;6(5):267-72. doi: 10.1080/15459620902754703. J Occup Environ Hyg. 2009. PMID: 19204865
Management of Parkinson's disease in Ayurveda: Medicinal plants and adjuvant measures.
Pathak-Gandhi N, Vaidya AD. Pathak-Gandhi N, et al. J Ethnopharmacol. 2017 Feb 2;197:46-51. doi: 10.1016/j.jep.2016.08.020. Epub 2016 Aug 17. J Ethnopharmacol. 2017. PMID: 27544001 Review.
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N. Hattori N. Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Rinsho Shinkeigaku. 2004. PMID: 15287506 Review. Japanese.
The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
Lindsay RM, Altar CA, Cedarbaum JM, Hyman C, Wiegand SJ. Lindsay RM, et al. Exp Neurol. 1993 Nov;124(1):103-18. doi: 10.1006/exnr.1993.1181. Exp Neurol. 1993. PMID: 8282068 Review.